▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / KMPB

KMPB — KEMPER Corp

—
NYSE · Financials · Insurance · CIK 860748 ·
Last close
$24.70
Market Cap
—
52W High
$24.86
52W Low
$23.16
ADV30
12,152
Next earnings
—
Adaptin Bio, Inc., a biotechnology company, develops drug delivery technologies to deliver drugs and other compounds directly to target destinations within the body in the United States. It provides Brain Bispecific T-cell Engager platform, a bispecific antibody technology to target and treat intracerebral malignancies, such as gliomas. It develops APTN-101, a proprietary epidermal growth factor receptor variant III to eliminate malignant glioma tumors in a range of aggressive preclinical tumor models. It caters to patients with oncology, CNS, autoimmune, and cardiovascular conditions, as well as healthcare professionals, researchers, and biopharma partners. The company was founded in 2021 and is based in Charlotte, North Carolina.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2024 1,178,900,000 1,178,900,000 871,700,000 73,700,000 12,630,400,000 — 9,846,100,000
Dec 2023 1,199,400,000 1,199,400,000 938,000,000 -146,300,000 12,742,700,000 — 10,237,700,000
Dec 2022 1,361,500,000 1,361,500,000 1,057,000,000 -74,800,000 13,313,600,000 212,400,000 10,643,000,000
Dec 2021 1,455,400,000 1,455,400,000 1,132,400,000 -75,300,000 14,916,500,000 148,200,000 10,908,800,000

Annual Trend (SEC EDGAR, last 10y)

Revenues vs Net Income (last 10y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 4,944,200,000 -347,100,000 -272,100,000 12,630,400,000 9,846,100,000 — —
Dec 2023 5,523,900,000 -371,000,000 -286,600,000 12,742,700,000 10,237,700,000 — —
Dec 2022 5,718,500,000 -249,300,000 -123,700,000 13,313,600,000 10,643,000,000 — —
Dec 2021 5,205,700,000 510,100,000 409,900,000 14,916,500,000 10,908,800,000 — —
Dec 2020 5,039,200,000 661,600,000 531,100,000 14,341,900,000 9,778,500,000 — —
Dec 2019 1,236,300,000 194,700,000 155,300,000 12,989,100,000 9,016,800,000 — —
Dec 2018 693,000,000 67,000,000 53,800,000 11,544,900,000 8,494,800,000 — —
Dec 2017 651,400,000 -3,500,000 -300,000 8,376,200,000 6,260,600,000 — —
Dec 2016 611,300,000 -6,500,000 -2,100,000 8,210,500,000 6,235,300,000 — —
Dec 2015 499,200,000 17,800,000 13,500,000 8,036,100,000 6,043,700,000 — —

TTM Snapshot

Revenues TTM
$5,195,200,000
NetIncome TTM
$-222,700,000
OpCashFlow TTM
$0
Assets (Latest)
$12,630,400,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
BRK-B BERKSHIRE HATHAWAY INC $715.29B $511.54 —
BRK-A BERKSHIRE HATHAWAY INC $387.67B $766600.00 —
UNH UNITEDHEALTH GROUP INC $376.34B $414.40 —
CB Chubb Ltd $135.29B $350.68 —
PGR PROGRESSIVE CORP/OH/ $122.92B $211.42 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →